---
figid: PMC4417610__nihms561650f2
figlink: /pmc/articles/PMC4417610/figure/F2/
number: Fig. 2
caption: Summary of the HGF/c-Met signaling pathway. HGF/c-Met signal transduction
  is initiated by binding of HGF to c-Met, as with other receptor tyrosine kinases.
  Dimerization or oligomerization of c-Met activates transphosphorylation of tyrosines
  (Tyr1234 and Tyr 1235) in the kinase domain followed by additional phosphorylation
  of other tyrosines (Tyr 1349 and Tyr 1356) in the C-terminal regulatory tail. Fully
  activated c-Met propagates HGF signaling in cells by recruiting and activating various
  adapter molecules downstream. Inhibitors of the HGF/c-Met signaling pathway, competitive
  inhibitors (A), tyrosine kinase inhibitors (B) or downstream inhibitors (C), target
  one of the molecular events of HGF/c-Met signaling activation and transduction.
pmcid: PMC4417610
papertitle: The hepatocyte growth factor/c-Met signaling pathway as a therapeutic
  target to inhibit angiogenesis.
reftext: Weon-Kyoo You, et al. BMB Rep. ;41(12):833-839.
pmc_ranked_result_index: '3474'
pathway_score: 0.9557271
filename: nihms561650f2.jpg
figtitle: Summary of the HGF/c-Met signaling pathway
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4417610__nihms561650f2.html
  '@type': Dataset
  description: Summary of the HGF/c-Met signaling pathway. HGF/c-Met signal transduction
    is initiated by binding of HGF to c-Met, as with other receptor tyrosine kinases.
    Dimerization or oligomerization of c-Met activates transphosphorylation of tyrosines
    (Tyr1234 and Tyr 1235) in the kinase domain followed by additional phosphorylation
    of other tyrosines (Tyr 1349 and Tyr 1356) in the C-terminal regulatory tail.
    Fully activated c-Met propagates HGF signaling in cells by recruiting and activating
    various adapter molecules downstream. Inhibitors of the HGF/c-Met signaling pathway,
    competitive inhibitors (A), tyrosine kinase inhibitors (B) or downstream inhibitors
    (C), target one of the molecular events of HGF/c-Met signaling activation and
    transduction.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SLTM
  - PIK3R4
  - KRAS
  - PTK2
  - HRAS
  - GRB2
  - SOS1
  - HGF
  - GAB1
  - AKT3
  - AKT1
  - AKT2
  - PIK3CG
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - MAPK3
  - MAP2K1
  - MAP2K2
  - STAT3
  - PIK3R6
  - BRAF
  - SRC
  - PIK3R3
  - TYR
  - SOS2
  - RAF1
  - MAPK1
  - NRAS
  - ARAF
  - Tyrosine
  - Tyr
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: c-Met
  symbol: Met
  source: hgnc_alias_symbol
  hgnc_symbol: SLTM
  entrez: '79811'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: FAK,
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: (SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: Gab1
  symbol: GAB1
  source: hgnc_symbol
  hgnc_symbol: GAB1
  entrez: '2549'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: STAT3=
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Tyr
  symbol: TYR
  source: hgnc_symbol
  hgnc_symbol: TYR
  entrez: '7299'
- word: (SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
chemicals:
- word: Tyrosine
  source: MESH
  identifier: D014443
- word: Tyr
  source: MESH
  identifier: D014443
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
